Yongwei Yu

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Aircraft performance and flight control systemsRespiratory diseasesMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 28, 2026
Model-Informed Ceftazidime-Avibactam Dosing Stratified by Renal Function and Renal Replacement Therapy Status in Critically Ill Patients: A Prospective Population Pharmacokinetic and Monte Carlo Simulation Study.

|Jul 14, 2026
Comparative Prognostic Performance of SOFA2.0 and SOFA for 28-Day Mortality in Patients Developing Sepsis During ECMO Support.

|Mar 16, 2026
Prolonged Thromboelastography R Time and Thrombocytopenia as Early Warning Indicators of Bleeding in ECMO Patients Who Developed Sepsis During Support: A Retrospective Cohort Study.

Mi Xu, Hao Xu, Yong-Wei Yu

|Dec 30, 2024
Pharmacokinetic Changes and Influencing Factors of Polymyxin B in Different ECMO Modes.

Mi Xu, Na Chen, Yong-Wei Yu

|Oct 11, 2024
Association Between Cerebral Microbleeds and Neurological Outcomes in Patients Who Underwent Extracorporeal Membrane Oxygenation.

Zhipeng Xu, Jingchen Zhang, Xing Fang

|May 22, 2024
Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.

Zhi-Hui Lin, Hua-Qiang Xiang, Yong-Wei Yu

Pageof 2

Frequent Collaborators

1 joint publications

Zhi-Hui Lin

1 joint publications

Hua-Qiang Xiang

1 joint publications

Yang-Jing Xue

1 joint publications

Chang Wu